Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05271851 · ClinicalTrials.gov registry record
Tailoring Mindfulness Interventions for Families Managing Chronic Health Conditions
A clinical trial, sponsored by University of Maryland, College Park.
- Completed
- Registry status
- 34
- Enrollment target
NCT05271851: Completed study, sponsored by University of Maryland, College Park.
NCT05271851 is a clinical trial that has completed, run by University of Maryland, College Park. The registered enrollment target is 34 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05271851 has completed, sponsored by University of Maryland, College Park.
- COMPLETED
- Registry status
- 34 participants
- Enrollment target
Study Summary
This is not an intervention or treatment study. It is an observational qualitative data study about tailoring a mindfulness intervention to assist families managing chronic health conditions.
Primary Outcome
structured open ended questions analyzed with grounded theory- no quantitative data will be captured
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2020-03-01 |
| Est. Completion | 2021-07-01 |
What the finished NCT05271851 record still lists
NCT05271851 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 34 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT05271851 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05271851 about?
NCT05271851 is a clinical study titled "Tailoring Mindfulness Interventions for Families Managing Chronic Health Conditions". This is not an intervention or treatment study. It is an observational qualitative data study about tailoring a mindfulness intervention to assist families managing chronic health conditions.
What is the current status of trial NCT05271851?
This trial is currently completed. The enrollment target is 34 participants. The study started on 2020-03-01. Estimated completion is 2021-07-01.
Who is sponsoring clinical trial NCT05271851?
This trial is sponsored by University of Maryland, College Park, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI